Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 113

PDF Downloaded: 42


Get Permission Punniamurthy, Wadwekar, and Srinivasan: Analysis of retinal thickness using spectral domain optical coherence tomography in hypertensives and normotensives: A comparative study


Introduction

Hypertension (HTN) is a multi system disease with the potential for profound effects on various organs of the body, including the eye. It is generally asymptomatic, but when it affects the eye, it can herald serious systemic effects. The most common manifestation of systemic HTN in the eye is hypertensive retinopathy (HTR).1

The hypertensive retinal vascular changes include generalized arteriolar narrowing, focal arteriolar narrowing, arteriovenous nicking, arterial wall opacification, micro aneurysms, blot and flame-shaped hemorrhages, cotton wool spots, hard exudates, and disc swelling. These are visualized by retinal examination, at various stages.2

Spectral domain optical coherence tomography (SD-OCT) is a non-invasive modality used to evaluate the various retinal layers and the optic disc. It is widely used as a diagnostic tool in glaucoma, diabetic retinopathy, and macular disorders.3, 4

The change in the macular thickness measured with OCT is one of the indicators of macular disease and index for diagnosis and treatment of macular pathology. In addition to genetic factors, many other factors, including age, sex, axial length, fasting glucose, and ethnicity, have been suggested to affect macular thickness.5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 Studies using SD-OCT have revealed changes in Retinal Nerve Fiber Layer (RNFL) thickness, with the change in blood pressure.15, 16, 17 Limited knowledge is available regarding the effect of high systemic blood pressure (BP) on macular and RNFL thickness.18, 19 Hence we conducted this study with the primary objective to compare the thickness of the central macula, RNFL, and Ganglion Cell Inner Plexiform Layers (GCIPL) using Spectral-domain Optical Coherence Tomography (SD-OCT) in hypertensive and normotensive adults. This may be indicative of vascular damage and also form the basis of new evidence in the interpretation of Central Macular thickness (CMT) and RNFL change in hypertensives.

Materials and Methods

This is a case control study done in a tertiary care hospital in south India. All necessary approval was taken from the institutional research and ethics committee. The study was carried out in accordance with the Declaration of Helsinki. Assuming the means as 98.31 and SD 7.01 in group A and mean as 102.51 and SD 8.72 in group B with significance as 5% and power 80% the sample size was 60 in each group.

Inclusion criteria

The patients attending the ophthalmology and general medicine outpatient department, who fulfilled the eligibility criteria were selected for the study. The written informed consent was obtained before participants were recruited for the study. All patients with systemic hypertension above18 years of age were included in Group A. Age-matched patients without hypertension (normotensives controls) were included in group B.

Exclusion criteria

Patients who had glaucoma, optic nerve disease, other retinal or macular disease, recent intraocular surgery, media haze which precludes a good scan, high myopia, secondary HTN, gestational HTN, and malignant HTN, were excluded from the study. The patient’s demographic details were noted. A detailed history of hypertension was obtained including the duration of disease, treatment, and other comorbidities like diabetes, renal disease, coronary artery disease. Personal history about smoking, alcoholism, tobacco chewing was also recorded.

Methodology

General physical examination included systolic blood pressure (SBP) and diastolic blood pressure (DBP) measured manually using a sphygmomanometer. The patients were categorized into normotensive (SBP <130 and DBP<80), stage 1 HTN (SBP130-139 or DBP 80-89), stage 2 HTN (SBP 140 or higher or DBP 90 or higher), and hypertensive crisis (SBP >180 and/or DBP>120) based on American Heart Association classification. One or both eyes of a patient were included for the study as per inclusion criteria. A standard eye examination, including best-corrected visual acuity (using a Snellen chart), retinoscopy, intraocular pressure (using applanation tonometry), and slit-lamp microscopy were done. The pupils were dilated using tropicamide 1% eye drops and fundoscopy (using 90D lens) was performed. Retinopathy was graded by Keith Wagener classification. The retinal imaging was performed using NIDEK Retina Scan Duo 330 SD-OCT a non-invasive imaging modality. Two scans of each macula map and disc map were obtained both with a signal strength of more than 7/10 and with good centration. The details collected were documented in the case report form and the printout of the SD-OCT was attached to it and used for future reference. The main Parameters studied were CMT, RNFL, and GCIPL.

Statistical analysis

The data were analyzed with statistical package for the social sciences software (SPSS) version-21. Categorical data were expressed in terms of percentage. Continuous data were expressed as mean +/- Standard deviation. An odds ratio and t-test were performed. A probability value (p-value) of <0.05 is considered significant

Results

Group A consisted of 60 eyes of 35 with a male to female ratio of 20:15 females and group B consisted of 60 eyes of 34 patients with a male to female ratio of 21:13. The mean age in group A was 52.43±10.35 years and in group B was 51.47±10.27years. The mean ± SD duration of hypertension in group A was 6.41±6.28 years. In group A 18 patients had stage 1 HTN, 16 patients’ stage 2 HTN, and one patient had a hypertensive crisis. In group A, two patients had a history of stroke and nine patients had a history of diabetes and in group B, one patient had a history of stroke and six patients had a history of diabetes. According to Keith-Wagener-Barker classification, a total of 14 patients had HTR in group A, out of which seven patients had grade 1 HTR, four patients had grade 2 HTR and three patients had grade 3 HTR. The CMT of cases was less than controls. However, there was no statistically significant difference in CMT (P = 0.1597) and subgroup analysis of macular thickness in all four quadrants in the outer and inner circle (Table 1).

Table 1

Comparison of macular thickness between the cases and controls

Macular Thickness (mean+ SD in µm)

Cases

Controls

P value

Central Macular thickness

251.03 ± 18.25

256.77 ± 15.09

0.1597

Inner superior

313.95 ± 26.43

322.01 ± 21.89

0.1730

Inner temporal

309.74 ± 16.88

316.65 ± 15.49

0.0812

Inner inferior

325.01 ± 17.47

330.06 ± 14.84

0.2007

Inner nasal

323.09 ± 19.05

330.77 ± 16.46

0.0780

Outer superior

297.82 ± 14.48

296.73 ± 18.69

0.7870

Outer temporal

282.06 ± 14.02

283.47 ± 13.89

0.6761

Outer inferior

279.69 ± 15.60

281.30 ± 16.71

0.6803

Outer nasal

304.68 ± 17.26

306.51 ± 16.04

0.6499

Table 2

Comparison of GCIPL thickness between cases and control

GCIPL thickness (mean+SD in µm)

Cases

Control

P-value

GCIPL Superior

98.76 ± 9

97.61+ 7.75

0.5719

GCIPL Inferior

100.95 ± 8.65

100.07 ± 7.01

0.6445

Superotemporal

91.73 ± 9

95.11 ± 13.79

0.0795

Inferotemporal

106.98 ± 12.27

110.38 ± 10.29

0.2173

Inferonasal

109.54 ± 13.63

112.61 ± 11.65

0.3188

Superonasal

98.77 +16.09

101.60 ± 16.76

0.4767

[i] GCIPL: Ganglion cell inner plexiform thickness

Table 3

Comparison of RNFL thickness between cases and controls

RNFL thickness (mean+SD in µm)

Cases

Control

P-value

Inferior

129.19 ± 20.88

127.74 ± 16.12

0.7483

Superior

132.07 ± 24.51

125.39 ± 16.89

0.1932

Nasal

79.76 ±13.80

71.25 ± 14.93

0.0164*

Temporal

68.38 ± 11.37

67.69 ± 9.41

0.7848

Average

102.25 ± 12.81

98.04 ±10.61

0.1424

[i] RNFL: Retinal Nerve Fiber Layer, *Nasal quadrant in cases had significant thickening of RNFL

Table 4

Comparison of duration of hypertension with CMT, GCIPL-S, GCIPL-I, RNFL

Hypertension< 10 years (mean±SD) (n=23)

Hypertension >10 years (mean±SD) (n=12)

P value

CMT

253.1 ± 9.41

248.89 ± 15.16

0.3204

GCIPL – S

99.84 ± 9.23

96.26 ± 8.81

0.2880

GCIPL – I

102.18 ± 8.24

98.15 ± 9.28

0.2054

RNFL

102.75 ± 13.15

101.10 ± 12.23

0.7272

[i] CMT: Central Macular Layer Thickness, GCIPL-S: Ganglion cell inner plexiform thickness-Superior, GCIPL-I: Ganglion cell inner plexiform thickness-Inferior, RNFL: Retinal Nerve Fiber Layer

Table 5

Change of retinal thickness with age

Age group (yrs.)

CMT

GCIPL – S

GCIPL – I

RNFL

30-40

257 ± 17.94

104.9 ± 4.90

107.2 +± 5.25

108.05 ± 10.31

41-50

251.69 ± 16.15

99.65 ± 7.14

101.76 ± 6.24

100.56 ± 11.88

51-60

259 ±17.11

96.16 ± 9.18

98.85 ± 7.97

97.42 ± 11.09

61-70

247.72 ± 14.19

91.72 ± 7.14

93.73 ±7.64

96.56 ± 12.13

[i] CMT: Central Macular Layer Thickness, GCIPL-S: Ganglion cell inner plexiform thickness-Superior, GCIPL-I: Ganglion cell inner plexiform thickness-Inferior, RNFL: Retinal Nerve Fiber Layer

There was a slight increase in the thickness of GCIPL of cases than controls in the inferior and superior quadrant. However, it was not statistically significant. The subgroup analysis of the thickness of GCIPL in all four quadrants was less for cases compared to controls, which were not statistically significant. Comparison of RNFL thickness in all four quadrants and average RNFL thickness in both groups shows that there is an increase in thickness in cases compared to controls and the difference was statistically significant in the nasal quadrant (P < 0.05) (Table 3)

Group A patient with a duration of HTN of more than 10 years had less CMT, average RNFL thickness, inferior and superior GCIPL thickness compared to patients who had HTN for less than 10 years, which was not statistically significant (Table 4).

As age advanced there was a decrease in CMT, RNFL thickness, and GCIPL thickness in superior and inferior quadrants in both cases and controls (Table 5)

Discussion

The current study found no statistically significant difference in CMT of hypertensive and normotensives. However, on quadrant wise analyses of the macula map, there was relatively more thinning in the inner temporal and inner nasal quadrant in cases. GCIPL showed relatively more thinning in the supero-temporal quadrant in hypertensives compared to normotensives. RNFL thickness analysis revealed that hypertensive patients had significant thickening- in the nasal quadrant compared to normotensive individuals. In our study, the mean age for the Hypertensive group was 52.43±10.35 years. Other studies in the literature also suggest the high prevalence of HTN in this age group.20, 21 Males were more than females in the hypertensive group in our study with a male: female of 1.3: 1 and correlates with male gender as a risk factor of HTN.19, 22

Lee SH et al. in his study found significant thinning of RNFL, macular, and GCIPL in chronic hypertensive (HTN > 10 years) patients than normotensive controls, and these retinal changes were more prominent in chronic hypertensives with retinopathy in the past. 18 In our series of cases too, macular thickness and GCIPL were found to be reduced in a hypertensive group compared to the normotensive group, but it was not statistically significant. This could be attributed to the average duration of HTN being comparatively less in our study (6.41±6.28 years). Further, Lee et al. also found that there was relatively more thinning in the supero- temporal quadrant in the GCIPL map which is similar to our results, and therefore it is possible that the thinning starts in this quadrant. Further, studies with long-term follow-up could confirm this finding. Our study also differed in that it showed relatively more thinning in the inner temporal (p=0.0812) and inner nasal (p=0.0780) quadrant on subgroup analysis of the macular map. This can be attributed to differences in study participants’ characteristics. In our study, we have recruited all patients with HTN irrespective of the duration and most of the patients had a duration of HTN of less than 10 years, this might have influenced the results. Our patients had reduced macular thickness despite no evidence of exudative retinopathy (only three out of 14 patients with HTR had exudative changes) a feature also noted by Kong M et al., where they found, reduced macular thickness (except CMT) in eyes without exudative HTR. This can be explained by autoregulation of retinal blood vessels induced by increased blood pressure leading to vasoconstriction and ischemia. The normal thickness of the central subfield of the macula can be due to foveal avascularity and hence the absence of any auto regulation.22 This could also be due to hypo perfusion resulting from ischemia due to over treatment. Most of the patients in the hypertensive group were on fair control with anti hypertensives, another possible reason for no significant thinning of macular and GCIPL thickness. The RNFL, is the axons of retinal ganglion cells, and hence we expect a decrease of RNFL thickness with decreased GCIPL thickness but, interestingly, we found increased RNFL thickness in all four quadrants in hypertensives when compared to normotensives. This difference was not statistically significant except in the nasal quadrant, which is in contradiction to a few other similar studies done in hypertensive patients.18, 19, 23 Khawaja AP found no positive correlation between HTN and RNFL thickness. Increase in RNFL thickness in the present study, could be attributed to subclinical disc edema because of possible acute elevation of blood pressure due to abnormal fluctuation and absence of chronic compensatory mechanism. This could possibly be due to the comparatively shorter duration of HTN, in our study population.24 Further studies are recommended to confirm this hypothesis. The average RNFL thickness in our study was comparable to the study done by Ramakrishnan R et al. They found that the thickness was more in the superior quadrant followed by inferior, nasal, and temporal quadrant which was similar to our results in group A.25, 26, 27 CMT was found highest in the age group 51-60 years and lowest in the age group 61-70 years. Few other studies have also shown that there was no association between age and macular thickness.28, 29, 30 GCIPL thickness was also found to decrease with age in our study in both cases and controls. This is supported by previous histological data, where the estimated loss of retinal ganglion cells for the age range studied was 7209 retinal ganglion cells/year.20, 31, 32, 33 RNFL, also showed decreased thickness with advancing age in both cases and controls, which is comparable with the other studies.19, 34, 35, 36 The decrease in RNFL thickness of 500 to 7000 axons per year was reported with increasing age in numerous histological studies also.26, 37 The macular, RNFL, and GCIPL thickness was reduced in patients who had HTN for more than 10 years compared to patients who had HTN for less than 10 years but it was not statistically significant. This can be attributable to hypertensive retinal ischemia. The majority of patients 65.71 % (23/35) in our study in group A had HTN for the duration of less than 10 years. Another study that included chronic hypertensive patients with a duration of more than 10 years found significant macular, RNFL, and GCIPL thinning in the hypertensive group compared to the normotensive group.18We have used SD-OCT in our study which is a 3rd generation OCT, that facilitates unprecedented ultra-high-resolution, ultra-high-speed RNFL imaging, which makes our results more accurate and strengthens our study.38 All patients were thoroughly evaluated by a physician who was also part of our study investigator team which ascertained that all patients were labeled hypertensive after proper evaluation by the medicine team at our institute. We had most hypertensive with a duration less than 10 years in our study which might have provided limited evidence for a causal association between HTN and macular thickness.

Conclusion

The present study supports the concept that CMT is less likely to be influenced by systemic HTN. Perifoveal macular thickness may be reduced. We recommend more studies including those with a longer duration of HTN.

RNFL thickness may increase in hypertensives compared to normotensives. We hypothesize that this could be due to possible acute rises in blood pressure and lesser duration of HTN in our study group. Aging is also found to reduce the GCIPL and RNFL and therefore it should be taken into consideration, along with those in HTN, while analyzing OCT parameters for glaucoma, neuro ophthalmological diseases, and other retinal conditions.

Ethical Approval

This study was done after taking approval from Institution ethics committee (IEC) approval number: RC/ 2018/97

Source of Funding

Nil.

Conflicts of Interest

Nil.

References

1 

DJ Ma HG Yu Window to Heart; Ocular Manifestations of HypertensionHanyang Med Rev20163614650

2 

M Bhargava MK Ikram TY Wong How does hypertension affect your eyes?J Hum Hypertens2022627183

3 

LA Paunescu JS Schuman LL Price PC Stark S Beaton H Ishikawa Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using Stratus OCTInvest Ophthalmol Vis Sci2004456171624

4 

JS Schuman TP Kloizman E Hertzmark MR Hee JR Wilkins JG Coker Reproducibility of nerve fiber layer thickness measurements using optical coherence tomographyOphthalmology199610311188998

5 

B Alamouti J Funk Retinal thickness decreases with age: an OCT studyBr J Ophthalmol2003877899901

6 

B Asefzadeh AA Cavallerano BM Fisch Racial differences in macular thickness in healthy eyesOptom Vis Sci200784109415

7 

XR Duan YB Liang DS Friedman LP Sun TY Wong QS Tao Normal macular thickness measurements using optical coherence tomography in healthy eyes of adult Chinese persons: the Handan Eye StudyOphthalmology20101178158594

8 

SC Huynh XY Wang E Rochtchina P Mitchell Distribution of macular thickness by optical coherence tomography: findings from a population-based study of 6-year-old childrenInvest Ophthalmol Vis Sci200647623517

9 

PJ Kelty JF Payne RH Trivedi J Kelty EM Bowie BM Burger Macular thickness assessment in healthy eyes based on ethnicity using Stratus OCT optical coherence tomographyInvest Ophthalmol Vis Sci2008496266872

10 

P Massin A Erginay B Haouchine AB Mehidi M Paques A Gaudric Retinal thickness in healthy and diabetic subjects measured using optical coherence tomography mapping softwareEur J Ophthalmol20021221028

11 

C Samarawickrama JJ Wang SC Huynh A Pai G Burlutsky KA Rose Ethnic differences in optic nerve head and retinal nerve fibre layer thickness parameters in childrenBr J Ophthalmol200994787176

12 

P Sony R Sihota HK Tewari P Venkatesh R Singh Quantification of the retinal nerve fiber layer thickness in normal Indian eyes with optical coherence tomographyIndian J Ophthalmol20045243039

13 

WK Song SC Lee ES Lee CY Kim SS Kim Macular thickness variations with sex, age, and axial length in healthy subjects: a spectral domain-optical coherence tomography studyInvest Ophthalmol Vis Sci201051839138

14 

Y Kwun J Sung Y Yang S Yang DI Ham YM Song Genetic influences on macular thickness in Koreans: the healthy twin studyInvest Ophthalmol Vis Sci2011521395236

15 

B Asefzadeh BM Fisch CE Parenteau AA Cavallerano Macular thickness and systemic markers for diabetes in individuals with no or mild diabetic retinopathyClin Experiment200836545563

16 

OZ Sahin SB Sahin T Avaz Z Karadag K Turkyilmaz E Aktas The impact of hypertension on retinal nerve fiber layer thickness and its association with carotis intima media thicknessBlood Press201524317884

17 

AP Khawaja MPY Chan DF Garway-Heath DC Broadway R Luben JC Sherwin Associations with retinal nerve fiber layer measures in the EPIC-Norfolk Eye StudyInvest Ophthalmol Vis Sci2013547502834

18 

SH Lee WH Lee HB Lim YJ Jo JY Kim Thicknesses of central macular, retinal nerve fiber, and ganglion cell inner plexiform layers in patients with hypertensionRetina201939918108

19 

KR Addoor SV Bhandary LG Rao S Kapoor Morphometric analysis of peripapillary thickness in hypertensives and normotensives using optical coherence tomography (OCT)J Clin Diagn Res201610714

20 

ME Lacruz A Kluttig S Hartwig M Löer D Tiller KH Greiser Prevalence and incidence of hypertension in the general adult population: results of the CARLA-cohort studyMedicine (Baltimore)20159422952

21 

T Raja T Muthukumar PA Mohan A cross-sectional study on prevalence of hypertension and its associated risk factors among rural adults in Kanchipuram district, Tamil NaduInt J Community Med Public Health20175124953

22 

M Kong Y Kwun J Sung D I Ham Y M Song Association between systemic hypertension and macular thickness measured by optical coherence tomographyInvest Ophthalmol Vis Sci201556214450

23 

RA Gangwani JWY Lee HY Mo R Sum ASK Kwong JHL Wang The correlation of retinal nerve fiber layer thickness with blood pressure in a chinese hypertensive populationMedicine (Baltimore)20159423947

24 

HM Lee WH Lee KN Kim YJ Jo JY Kim Changes in thickness of central macula and retinal nerve fibre layer in severe hypertensive retinopathy: a 1-year longitudinal studyActa Ophthalmol201896338692

25 

JB Jonas GC Gusek GO Naumann Optic disc, cup and neuroretinal rim size, configuration and correlations in normal eyesInvest Ophthalmol Vis Sci198829711518

26 

AG Balazsi J Rootman SM Drance M Schulzer GR Douglas The effect of age on the nerve fiber population of the human optic nerveAm J Ophthalmol19849767606

27 

R Ramakrishnan S Mittal S Ambatkar MA Kader Retinal nerve fibre layer thickness measurements in normal Indian population by optical coherence tomographyIndian J Ophthalmol2006541115

28 

M Adhi S Aziz K Muhammad MI Adhi Macular thickness by age and gender in healthy eyes using spectral domain optical coherence tomographyPLoS One20127537638

29 

AC Sull LN Vuong LL Price VJ Srinivasan I Gorczynska JG Fujimoto Comparison of spectral/Fourier domain optical coherence tomography instruments for assessment of normal macular thicknessRetina201030223545

30 

A Chan JS Duker TH Ko JG Fujimoto JS Schuman Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomographyArch Ophthalmol200612421938

31 

MX Repka HA Quigley The effect of age on normal human optic nerve fiber number and diameterOphthalmology19899612632

32 

FS Mikelberg SM Drance M Schulzer HM Yidegiligne MM Weis The normal human optic nerve. Axon count and axon diameter distributionOphthalmology198996913258

33 

LA Kerrigan-Baumrind HA Quigley ME Pease DF Kerrigan RS Mitchell Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same personsInvest Ophthalmol Vis Sci20004137418

34 

OS Punjabi RL Stamper AG Bostrom SC Lin Does treated systemic hypertension affect progression of optic nerve damage in glaucoma suspects?Curr Eye Res200732215360

35 

JY Won SE Kim YH Park Effect of age and sex on retinal layer thickness and volume in normal eyesMedicine (Baltimore)201695465441

36 

T Mansoori K Viswanath N Balakrishna Quantification of retinal nerve fiber layer thickness using spectral domain optical coherence tomography in normal Indian populationIndian J Ophthalmol20126065558

37 

CL Dolman AQ McCormick SM Drance Aging of the optic nerveArch Ophthalmol1980981120538

38 

CKS Leung CYL Cheung RN Weinreb Q Qiu S Liu H Li Retinal nerve fiber layer imaging with spectral- domain optical coherence tomography: a variability and diagnostic performance studyOphthalmology20091167125763



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Original Article


Article page

509-514


Authors Details

Rajarajeswary Punniamurthy, Bhagwati Wadwekar*, Renuka Srinivasan


Article History

Received : 10-08-2023

Accepted : 18-12-2023


Article Metrics


View Article As

 


Downlaod Files